<DOC>
	<DOCNO>NCT02520271</DOCNO>
	<brief_summary>Ostrobothnia Depression Study ( ODS ) conduct South Ostrobothnia hospital district Finland 2009-2014 . ODS naturalistic , open label , non-randomized follow-up study depression relate substance use disorder ( SUD ) . The study focus several aspect concern relation depression SUDs , efficacy select assessment treatment protocol , characteristic genetics participant use related biomarkers clinical practice . The misused substance focus alcohol . In study , dual diagnosis ( DD ) define simultaneous presence clinically diagnose major depressive disorder ( MDD ) alcohol use disorder ( AUD ) . The study approve local ethic committee . Written inform consent collect participant .</brief_summary>
	<brief_title>Ostrobothnia Depression Study ( ODS ) . A Naturalistic Follow-up Study Depression Related Substance Use Disorders</brief_title>
	<detailed_description>Participants The participant recruit five outpatient clinic one psychiatric hospital ward South Ostrobothnia hospital district ( population 200,000 ) 1.10.2009 - 31.10.2013 . Patients refer psychiatric secondary service depressive symptom , anxiety , self destructiveness , insomnia alcohol substance relate problem screen Beck depression inventory ( BDI , version 1A ) . Patients BDI score ≥ 17 screen phase recruit study . The patient likely verified psychotic disorder ( ICD-10 , F2* . ** diagnosis ) organic brain disease exclude . A total 242 patient include study . Fifty-three ( 21.9 % ) patient hospitalise baseline . The participant age 17-64 year ( mean 38.8 year , SD 12.2 ) . Among recruited 148 female ( 61.2 % ) 94 male ( 38.8 % ) . The Mini International Neuropsychiatric Interview 5.0 ( MINI ) make baseline 219 patient . At baseline 203 ( 84 % ) patient prescribe antidepressive medication , 81 % case either SSRI SNRI primary antidepressant ) . Antipsychotic medication prescribe 66 ( 28 % ) patient . At time recruitment participant divide two group base AUDIT -score . The patient baseline AUDIT-score ≥ 11 categorize patient comorbid AUD therefore dual diagnosis ( DD+ ) . The patient AUDIT ≤ 10 categorize ( DD- ) . The clinical psychiatric evaluation perform psychiatrist train professional use Mini International Neuropsychiatric Interview 5.0 ( MINI ) . The symptom MDD assess Montgomery-Åsberg Depression Rating Scale ( MADRS ) . The patient receive medication need medical treatment assess psychiatrist responsible treatment . The use psychotropic medication record . The choice medication leave clinician charge . All participant also evaluate three-dimensional model select follow treatment intervention . The model develop Kampman Lassila South Ostrobothnia hospital district describe detail Finnish Medical Journal . The model develop base need tool good ass patient DD clinical setting . The model use define patient ' problem accord three treatment relate factor ( diagnosis , substance use problem , level functioning ) . The model consist three dichotomous assessment lead score 0 1 point accord difficulty problem . The factor assess 1 ) psychiatric diagnosis ( non-psychotic/psychotic ; 0/1 point ) , 2 ) difficulty SUD ( moderate/difficult ; 0/1 point ) 3 ) patient level function accord Global Assessment Functioning ( GAF ) -scale ( good functioning/poor functioning ; 0/1 point ) . The give point add together form overall score 0 point ( modest DD problem ) 3 point ( difficult DD problem ) . Treatment intervention The treatment intervention include antidepressive medication ( SSRI ) , Behavioral Activation therapy ( BA ) FRAMES intervention , Motivational interview ( MI ) In participant AUDIT ≤ 10 ( DD- ) intervention start focus depression ( antidepressive medication BA ) . In patient AUDIT ≥ 11 ( DD+ ) intervention start focus AUD . If AUD evaluate moderate ( duration le 2 year , day sober last month ) first treatment select could either FRAMES MI . If AUD assess severe ( duration 2 year , active use day last month , poly-substance use , GAF &lt; 50 ) intervention suppose start MI . The intervention implement staff person responsible appointment certain patient ( nurse psychologist ) receive training use select intervention . The duration MI set approximately 3 ( 2-5 ) appointment . The minimum duration BA set 4 appointment . Follow-up The follow-up include appointment clinical research nurse 6 , 12 24 month point . During appointment severity recovery depression evaluate MADRS , alcohol use evaluate AUDIT , information substance use relapse collect , MINI-interview repeat 12 month point . Additionally , follow information collect : 15D-quality life scale , GAF-scale , laboratory test ( 6 month : blood count , electrolytes , creatinine , liver function ) , Body Mass Index , waist , smoke status .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Patients refer psychiatric secondary service 1 . Depressive symptoms 2 . Anxiety 3 . Selfdestructiveness 4 . Insomnia 5 . Alcohol substance relate problem , Beck depression inventory ( BDI , version 1A ) score least 17 screen phase . A likely verified ICD10 F2 category diagnosis ( psychotic disorder ) . Organic brain disease</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Mood Disorders</keyword>
	<keyword>Motivational Interview</keyword>
	<keyword>Behavioral Activation</keyword>
</DOC>